Live Breaking News & Updates on Adding Durvalumab To Concurrent Chemoradiation

Stay updated with breaking news from Adding durvalumab to concurrent chemoradiation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Concurrent Durvalumab/CRT Does Not Confer Significant Survival Advantage in Unresectable Stage III NSCLC

Durvalumab/chemoradiation did not significantly improve survival vs chemoradiation alone in patients with unresectable non–small cell lung cancer. ....

United States , Czech Republic , University Of Pennsylvania , Jeffreyd Bradley , Hospital Of The University Pennsylvania , European Lung Cancer Congress , Proton Therapy Technology Development , World Health Organization , Lung Cancer , Proton Therapy , Technology Development , Eastern Europe , Lung Cancer Congress , Adding Durvalumab To Concurrent Chemoradiation , Patients With Unresectable Stage Iii Non Small Cell Lung Cancer ,